Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-E Truchetet

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
La Revue De Medecine Interne|November 26, 2024
[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]L Chiche, M-E Truchetet, D Cornec, et al.
Annales De Dermatologie Et De Venereologie|May 14, 2026
Anifrolumab for refractory cutaneous manifestations of amyopathic dermatomyositisV Horiot, J Seneschal, M-E Truchetet, et al.
Medecine Et Maladies Infectieuses|June 13, 2017
Respiratory infections associated with anti-TNFα agentsE Blanchard, M-E Truchetet, I Machelart, et al.
Scientific Reports|September 10, 2021
Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patientsJ Lapoirie, L Tran, L Piazza, et al.
Annales De Dermatologie Et De Venereologie|June 30, 2009
[Feverish skin eruption]A Pham-Ledard, T Hubiche, M-E Truchetet, et al.
Bone|October 15, 2013
Bisphosphonate therapy for unresectable symptomatic benign bone tumors: a long-term prospective study of tolerance and efficacyF Cornelis, M E Truchetet, N Amoretti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2018
Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysisP Meunier, L Dequidt, T Barnetche, et al.
The British Journal of Dermatology|September 15, 2017
Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literatureA Eyraud, L Scouppe, T Barnetche, et al.
Clinical and Experimental Dermatology|May 13, 2016
Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosisA S Darrigade, A L Vedie, C Gauthier, et al.
La Revue De Medecine Interne|June 20, 2021
[Transition from pediatric to adult care: Recommendations of the French network for autoimmune and autoinflammatory diseases (FAI<sup>2</sup>R)]S Georgin-Lavialle, V Hentgen, M E Truchetet, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
La Revue De Medecine Interne|November 26, 2024
[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]L Chiche, M-E Truchetet, D Cornec, et al.
Annales De Dermatologie Et De Venereologie|May 14, 2026
Anifrolumab for refractory cutaneous manifestations of amyopathic dermatomyositisV Horiot, J Seneschal, M-E Truchetet, et al.
Medecine Et Maladies Infectieuses|June 13, 2017
Respiratory infections associated with anti-TNFα agentsE Blanchard, M-E Truchetet, I Machelart, et al.
Scientific Reports|September 10, 2021
Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patientsJ Lapoirie, L Tran, L Piazza, et al.
Annales De Dermatologie Et De Venereologie|June 30, 2009
[Feverish skin eruption]A Pham-Ledard, T Hubiche, M-E Truchetet, et al.
Bone|October 15, 2013
Bisphosphonate therapy for unresectable symptomatic benign bone tumors: a long-term prospective study of tolerance and efficacyF Cornelis, M E Truchetet, N Amoretti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2018
Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysisP Meunier, L Dequidt, T Barnetche, et al.
The British Journal of Dermatology|September 15, 2017
Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literatureA Eyraud, L Scouppe, T Barnetche, et al.
Clinical and Experimental Dermatology|May 13, 2016
Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosisA S Darrigade, A L Vedie, C Gauthier, et al.
La Revue De Medecine Interne|June 20, 2021
[Transition from pediatric to adult care: Recommendations of the French network for autoimmune and autoinflammatory diseases (FAI<sup>2</sup>R)]S Georgin-Lavialle, V Hentgen, M E Truchetet, et al.
Pageof 2